Medicine and Dentistry
Patient
100%
Overall Survival
25%
High Risk Population
16%
Survival
16%
Hemoglobin
8%
Metastatic Carcinoma
8%
Proportional Hazards Model
8%
Multivariate Analysis
8%
Pancreas Cancer
8%
Pancreas Adenocarcinoma
8%
Carcinoembryonic Antigen
8%
Risk Stratification
8%
Intermediate Risk Population
8%
Low Risk Population
8%
Association
8%
Therapeutic Procedure
8%
Nursing and Health Professions
Overall Survival
25%
High Risk Population
16%
Procedures
16%
Survival
16%
Hemoglobin
8%
Prognosis
8%
Metastasis
8%
Proportional Hazards Model
8%
Multivariate Analysis
8%
Carcinoembryonic Antigen
8%
Chemotherapy
8%
Neutrophil Lymphocyte Ratio
8%
Pancreas Cancer
8%
Leukocyte Count
8%
Device Material
8%
Parameters
8%
Low Risk Population
8%
Laboratory
8%
Pancreas Adenocarcinoma
8%
Intermediate Risk Population
8%
Biochemistry, Genetics and Molecular Biology
Overall Survival
25%
High Risk Population
16%
Survival
16%
Hemoglobin
8%
Leukocyte Count
8%
Carcinoembryonic Antigen
8%
Low Risk Population
8%
Multivariate Analysis
8%
Association
8%
Intermediate Risk Population
8%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
25%
Survival
16%
Metastasis
8%
Hemoglobin
8%
Carcinoembryonic Antigen
8%
Prognosis
8%
Pancreas Adenocarcinoma
8%
Pancreas Cancer
8%